Pasar al contenido principal

CATALIZADORES HIBRIDOS ORGANOENZIMATICOS

RTI2018-094637-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cascade enzymatic synthesis of L -homoserine – mathematical modelling as a tool for process optimisation and design

  • Česnik, Morana
  • Sudar, M.
  • Hernández, Karel
  • Charnock, Simon J.
  • Vasić-Rački, Đ.
  • Clapés Saborit, Pere
  • Findrik Blažević, Zvjezdana
L-Homoserine is an important compound and a building block in chemical and pharmaceutical industry. The one-pot cascade synthesis of L-homoserine with substrate recycling catalysed by an aldolase and a transaminase was investigated in detail, with special interest in the reaction’s kinetics and process development. Complex relationships between the process variables were discovered and the kinetic and reactor model were developed. In addition, new chemical insights were developed through this model-driven process development, and for the first time a kinetic model was proposed to describe the YfaU-catalysed reaction. The modelling was crucial for a better understanding of the reaction system, as well as for process optimisation. Finding a proper strategy for process improvement by manipulating the reaction conditions, as well as developing process design, was imperative to achieve the process metrics necessary for scale-up. Using the optimized reaction conditions in the fed-batch reactor with a continuous formaldehyde supply, and with subsequent addition of pyruvate and L-alanine, 80.1 g L–1 of L-homoserine was obtained with a volume productivity of 3.2 g L–1 h–1 after 25 h. These results present a 100% increase in product concentration and approximately 18% increase in volume productivity in comparison with previously published work. This work shows the benefit of the synergistic approach of bio(chemical) knowledge and process model development working hand-in-hand which is crucial for stronger breakthrough of biocatalysis to chemical industry., This project has received funding from the European Union’s Horizon 2020 Research and Innovation Program under Grant Agreement No. 635595 (CarbaZymes), Ministerio de Economía y Competitividad (MINECO), the Fondo Europeo de Desarrollo Regional (FEDER) (grant RTI2018-094637-B-I00) and Programación Conjunta Internacional PCI2018-092937, through the initiative ERA CoBioTech (Tralaminol). This communication reflects only the beneficiary’s view, and the European Commission is not responsible for any use that may be made of the information it contains. The authors gratefully acknowledge Prozomix Ltd (United Kingdom) for providing the enzymes., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Chemoenzymatic Hydroxymethylation of Carboxylic Acids by Tandem Stereodivergent Biocatalytic Aldol Reaction and Chemical Decarboxylation

  • Marín-Valls, Roser
  • Hernández Sánchez, Karel
  • Bolte, Michael
  • Joglar Tamargo, Jesús
  • Bujons, Jordi
  • Clapés Saborit, Pere
Chiral 2-substituted 3-hydroxycarboxylic acid derivatives are valuable building blocks for the preparation of naturally occurring and synthetic biologically active molecules. Current methodologies for the preparation of these compounds are still limited for large-scale production due to the high costs, limited microbial strains, low yields, difficult downstream processing, and limited range of structures. We report an effective chemoenzymatic method for the synthesis of enantiomerically pure 2-substituted 3-hydroxycarboxylic esters. The strategy comprises: (i) a stereoselective aldol addition of 2-oxoacids to methanal catalyzed by two enantiocomplementary 2-oxoacid aldolases, (ii) oxidative decarboxylation, and (iii) esterification. Compounds with S-configuration were obtained in 69-80% isolated yields (94-99% ee), and the R enantiomers in 57-88% (88-98% ee), using a substrate concentration range of 0.1-1.0 M. The method developed offers a versatile alternative route to this important class of chiral building blocks and highlights the exciting opportunities available for using natural enzymes with minimal active site modification. Copyright © 2019 American Chemical Society., This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 635595 (CarbaZymes), the Ministerio de Economía y Competitividad (MINECO), the Fondo Europeo de Desarrollo Regional (FEDER) (grant RTI2018-094637–B–I00), Programación Conjunta Internacional PCI2018-092937, through the initiative ERA CoBioTech. The authors gratefully acknowledge the “Consorci de Serveis Universitaris de Catalunya” (CSUC) for allowing the use of its software and hardware resources., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Biocatalytic Construction of Quaternary Centers by Aldol Addition of 3,3-Disubstituted 2-Oxoacid Derivatives to Aldehydes

  • Marín-Valls, Roser
  • Hernández Sánchez, Karel
  • Bolte, Michael
  • Parella, Teodor
  • Joglar Tamargo, Jesús
  • Bujons, Jordi
  • Clapés Saborit, Pere
The congested nature of quaternary carbons hinders their preparation, most notably when stereocontrol is required. Here we report a biocatalytic method for the creation of quaternary carbon centers with broad substrate scope, leading to different compound classes bearing this structural feature. The key step comprises the aldol addition of 3,3-disubstituted 2-oxoacids to aldehydes catalyzed by metal dependent 3-methyl-2-oxobutanoate hydroxymethyltransferase from E. coli (KPHMT) and variants thereof. The 3,3,3-trisubstituted 2-oxoacids thus produced were converted into 2-oxolactones and 3-hydroxy acids and directly to ulosonic acid derivatives, all bearing gem-dialkyl, gem-cycloalkyl, and spirocyclic quaternary centers. In addition, some of these reactions use a single enantiomer from racemic nucleophiles to afford stereopure quaternary carbons. The notable substrate tolerance and stereocontrol of these enzymes are indicative of their potential for the synthesis of structurally intricate molecules., This project has received funding from the Ministerio de Ciencia e Innovación (MICIN), the Fondo Europeo de Desarrollo Regional (FEDER) (grant RTI2018-094637-B-I00 to P.C. and PGC2018-095808-B-I00 to T.P.), and Programación Conjunta Internacional (PCI2018-092937), through the initiative ERA CoBioTech (Tralaminol). The authors gratefully acknowledge the “Consorci de Serveis Universitaris de Catalunya” (CSUC) for allowing the use of its software and hardware resources., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Chemoenzymatic Production of Enantiocomplementary 2‐Substituted 3‐Hydroxycarboxylic Acids from l‐α‐Amino Acids

  • Pickl, Mathias
  • Marín-Valls, Roser
  • Joglar, Jesús
  • Bujons, Jordi
  • Clapés Saborit, Pere
A two‐enzyme cascade reaction plus in situ oxidative decarboxylation for the transformation of readily available canonical and non‐canonical l‐α‐amino acids into 2‐substituted 3‐hydroxycarboxylic acid derivatives is described. The biocatalytic cascade consisted of an oxidative deamination of l‐α‐amino acids by an l‐α‐amino acid deaminase from Cosenzaea myxofaciens, rendering 2‐oxoacid intermediates, with an ensuing aldol addition reaction to formaldehyde, catalyzed by metal‐dependent (R)‐ or (S)‐selective carboligases namely 2‐oxo‐3‐deoxy‐l‐rhamnonate aldolase (YfaU) and ketopantoate hydroxymethyltransferase (KPHMT), respectively, furnishing 3‐substituted 4‐hydroxy‐2‐oxoacids. The overall substrate conversion was optimized by balancing biocatalyst loading and amino acid and formaldehyde concentrations, yielding 36–98% aldol adduct formation and 91–98% ee for each enantiomer. Subsequent in situ follow‐up chemistry via hydrogen peroxide‐driven oxidative decarboxylation afforded the corresponding 2‐substituted 3‐hydroxycarboxylic acid derivatives., This project has received funding from Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación, Fondo Europeo de Desarrollo Regional (FEDER) (grants RTI2018‐094637‐B‐I00) and Programación Conjunta Internacional PCI2018‐092937 under the ERACoBioTech (European Union's Horizon 2020 research and innovation programme under grant agreement No [722361]. This research was funded in part by the Austrian Science Fund (FWF) [J 4227‐B21]. M. P. acknowledges funding by the Austrian FWF through an Erwin Schrödinger fellowship.. The PmaLAAD expression plasmid was a generous gift from Prof. Wolfgang Kroutil (University of Graz)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synthesis of γ-Hydroxy-α-amino Acid Derivatives by Enzymatic Tandem Aldol Addition–Transamination Reactions

  • Moreno, Carlos J.
  • Hernández Sánchez, Karel
  • Charnock, Simon J.
  • Gittings, Samantha
  • Bolte, Michael
  • Joglar Tamargo, Jesús
  • Bujons, Jordi
  • Parella, Teodor
  • Clapés Saborit, Pere
Three enzymatic routes toward γ-hydroxy-α-amino acids by tandem aldol addition–transamination one-pot two-step reactions are reported. The approaches feature an enantioselective aldol addition of pyruvate to various nonaromatic aldehydes catalyzed by trans-o-hydroxybenzylidene pyruvate hydratase-aldolase (HBPA) from Pseudomonas putida. This affords chiral 4-hydroxy-2-oxo acids, which were subsequently enantioselectively aminated using S-selective transaminases. Three transamination processes were investigated involving different amine donors and transaminases: (i) l-Ala as an amine donor with pyruvate recycling, (ii) a benzylamine donor using benzaldehyde lyase from Pseudomonas fluorescens Biovar I (BAL) to transform the benzaldehyde formed into benzoin, minimizing equilibrium limitations, and (iii) l-Glu as an amine donor with a double cascade comprising branched-chain α-amino acid aminotransferase (BCAT) and aspartate amino transferase (AspAT), both from E. coli, using l-Asp as a substrate to regenerate l-Glu. The γ-hydroxy-α-amino acids thus obtained were transformed into chiral α-amino-γ-butyrolactones, structural motifs found in many biologically active compounds and valuable intermediates for the synthesis of pharmaceutical agents., This project has received funding from the Ministerio de Ciencia e Innovación (MICIN), cofinanced by the Fondo Europeo de Desarrollo Regional (FEDER) (grants RTI2018-094637-B-I00 to P.C. and PGC2018-095808-B-I00 to T.P.), and Programación Conjunta Internacional (PCI2018-092937), through the EU initiative ERA CoBioTech under grant agreement No [722361] to P.C and S.J.Ch.) (Tralaminol)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Enantioselective Reductive Oligomerization of Carbon Dioxide into l-Erythrulose via a Chemoenzymatic Catalysis

  • Desmons, Sarah
  • Grayson-Steel, Katie
  • Nuñez-Dallos, Nelson
  • Vendier, Laure
  • Hurtado, John
  • Clapés Saborit, Pere
  • Fauré, Regis
  • Dumon, Claire
  • Bontemps, Sébastien
A cell-free enantioselective transformation of the carbon atom of CO2 has never been reported. In the urgent context of transforming CO2 into products of high value, the enantiocontrolled synthesis of chiral compounds from CO2 would be highly desirable. Using an original hybrid chemoenzymatic catalytic process, we report herein the reductive oligomerization of CO2 into C3 (dihydroxyacetone, DHA) and C4 (l-erythrulose) carbohydrates, with perfect enantioselectivity of the latter chiral product. This was achieved with the key intermediacy of formaldehyde. CO2 is first reduced selectively by 4e– by an iron-catalyzed hydroboration reaction, leading to the isolation and complete characterization of a new bis(boryl)acetal compound derived from dimesitylborane. In an aqueous buffer solution at 30 °C, this compound readily releases formaldehyde, which is then involved in selective enzymatic transformations, giving rise either (i) to DHA using a formolase (FLS) catalysis or (ii) to l-erythrulose with a cascade reaction combining FLS and d-fructose-6-phosphate aldolase (FSA) A129S variant. Finally, the nature of the synthesized products is noteworthy, since carbohydrates are of high interest for the chemical and pharmaceutical industries. The present results prove that the cell-free de novo synthesis of carbohydrates from CO2 as a sustainable carbon source is a possible alternative pathway in addition to the intensely studied biomass extraction and de novo syntheses from fossil resources., We wish to thank the reviewers, whose comments helped to improve the manuscript and in particular the 1H NMR interpretation of compound 3-13C. S.D. thanks Région Midi-Pyrénées and Université Fédérale de Toulouse for a doctoral fellowship. S.B. thanks the ANR programme JCJC “ICC”. C. Bijani is gratefully acknowledged for his help in the simulation of 3-13C. K.G.-S., C.D., and R.F. thank the Carnot 3BCAR (project SUCRES), including the fellowship of K.G.-S. R.F. thanks the Mission for Transversal and Interdisciplinary Initiatives of the CNRS (project CASCADE). We gratefully thank N. Monties, S. Pizzut, and M. Guicherd for technical assistance in HPLC experiments, G. Cioci for assistance in DSF experiments and protein purification, and the ICEO facility dedicated to enzyme screening and discovery, part of the Integrated Screening Platform of Toulouse (PICT, IBiSA). DSF is part of the Integrated Screening Platform of Toulouse (PICT, IBiSA). We thank S. Heux and A. De Simone for the generous gift of a plasmid containing the gene encoding for FLS. J. Durand is gratefully acknowledged for his help in isolating compound 4-13C by semipreparative HPLC. P.C. thanks the Ministerio de Ciencia e Innovación (MICIN), the Fondo Europeo de Desarrollo Regional (FEDER) (grant RTI2018-094637-B-I00), and Programación Conjunta Internacional (PCI2018-092937), through the initiative ERA CoBioTech, Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Synthesis of γ-Hydroxy-α-amino Acid Derivatives by Enzymatic Tandem Aldol Addition-Transamination Reactions

  • Moreno, Carlos J.
  • Hernández, Karel|||0000-0001-7367-4426
  • Charnok, Simon J.
  • Gittings, Samantha
  • Bolte, Michael|||0000-0001-5296-6251
  • Joglar, Jesús|||0000-0002-3391-1682
  • Bujons, Jordi|||0000-0003-2944-2905
  • Parella Coll, Teodor|||0000-0002-1914-2709
  • Clapés, Pere|||0000-0001-5541-4794
Three enzymatic routes toward γ-hydroxy-α-amino acids by tandem aldol addition-transamination one-pot two-step reactions are reported. The approaches feature an enantioselective aldol addition of pyruvate to various nonaromatic aldehydes catalyzed by trans - o -hydroxybenzylidene pyruvate hydratase-aldolase (HBPA) from Pseudomonas putida. This affords chiral 4-hydroxy-2-oxo acids, which were subsequently enantioselectively aminated using S -selective transaminases. Three transamination processes were investigated involving different amine donors and transaminases: (i) -Ala as an amine donor with pyruvate recycling, (ii) a benzylamine donor using benzaldehyde lyase from Pseudomonas fluorescens Biovar I (BAL) to transform the benzaldehyde formed into benzoin, minimizing equilibrium limitations, and (iii) -Glu as an amine donor with a double cascade comprising branched-chain α-amino acid aminotransferase (BCAT) and aspartate amino transferase (AspAT), both from E. coli, using -Asp as a substrate to regenerate -Glu. The γ-hydroxy-α-amino acids thus obtained were transformed into chiral α-amino-γ-butyrolactones, structural motifs found in many biologically active compounds and valuable intermediates for the synthesis of pharmaceutical agents.